XML 49 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 17 - Reportable Segments (Tables)
6 Months Ended
Jun. 30, 2016
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
 
Display
Technologies
 
Optical
Communications
 
Environmental
Technologies
 
Specialty
Materials
 
Life
Sciences
 
All
Other
 
Total
Three months ended
  June 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
801 
 
$
782 
 
$
259 
 
$
266 
 
$
215 
 
$
37 
 
$
2,360 
 
Depreciation 
(1)
$
149 
 
$
43 
 
$
33 
 
$
27 
 
$
13 
 
$
11 
 
$
276 
 
Amortization of purchased intangibles
 
 
 
$
 
 
 
 
 
 
 
$
 
$
 
$
15 
 
Research, development and engineering expenses 
(2)
$
17 
 
$
36 
 
$
26 
 
$
34 
 
$
 
$
45 
 
$
164 
 
Restructuring, impairment and other charges
$
 
 
 
 
 
 
 
$
12 
 
$
 
$
 
$
16 
 
Equity in earnings of affiliated companies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
(8)
 
$
(8)
 
Income tax (provision) benefit
$
(86)
 
$
(39)
 
$
(19)
 
$
(19)
 
$
(8)
 
$
23 
 
$
(148)
 
Net income (loss) 
(3)
$
204 
 
$
77 
 
$
37
 
$
38 
 
$
17 
 
$
(55)
 
$
318 
 
Display
Technologies
 
Optical
Communications
 
Environmental
Technologies
 
Specialty
Materials
 
Life
Sciences
 
All
Other
 
Total
Three months ended
  June 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
789 
 
$
800 
 
$
260 
 
$
272 
 
$
211 
 
$
11 
 
$
2,343 
 
Depreciation 
(1)
$
152 
 
$
43 
 
$
32 
 
$
27 
 
$
15 
 
$
11 
 
$
280 
 
Amortization of purchased intangibles
 
 
 
$
11 
 
 
 
 
 
 
 
$
 
 
 
 
$
16 
 
Research, development and engineering expenses 
(2)
$
26 
 
$
35 
 
$
23 
 
$
29 
 
$
 
$
44 
 
$
163 
 
Restructuring, impairment and other charges
 
 
 
 
 
 
 
 
 
$
 
 
 
 
 
 
 
$
 
Equity in earnings of affiliated companies
$
(3)
 
 
 
 
 
 
 
 
 
 
 
 
 
$
 
$
 
Income tax (provision) benefit
$
(136)
 
$
(37)
 
$
(22)
 
$
(22)
 
$
(9)
 
$
21 
 
$
(205)
 
Net income (loss) 
(3)
$
303 
 
$
77 
 
$
46 
 
$
44 
 
$
18 
 
$
(45)
 
$
443 
 
Display
Technologies
 
Optical
Communications
 
Environmental
Technologies
 
Specialty
Materials
 
Life
Sciences
 
All
Other
 
Total
Six months ended
  June 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
1,506 
 
$
1,391 
 
$
523 
 
$
493 
 
$
419 
 
$
75 
 
$
4,407 
 
Depreciation 
(1)
$
300 
 
$
84 
 
$
65 
 
$
55 
 
$
28 
 
$
22 
 
$
554 
 
Amortization of purchased intangibles
 
 
 
$
15 
 
 
 
 
 
 
 
$
10 
 
$
 
$
29 
 
Research, development and engineering expenses 
(2)
$
35 
 
$
73 
 
$
51 
 
$
65 
 
$
12 
 
$
92 
 
$
328 
 
Restructuring, impairment and other charges
$
16 
 
$
 
$
 
$
24 
 
$
 
$
61 
 
$
117 
 
Equity in earnings of affiliated companies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
(5)
 
$
(5)
 
Income tax (provision) benefit
$
(179)
 
$
(50)
 
$
(35)
 
$
(31)
 
$
(14)
 
$
66 
 
$
(243)
 
Net income (loss) 
(3)
$
413 
 
$
94 
 
$
71
 
$
64 
 
$
29 
 
$
(140)
 
$
531 
 
Display
Technologies
 
Optical
Communications
 
Environmental
Technologies
 
Specialty
Materials
 
Life
Sciences
 
All
Other
 
Total
Six months ended
  June 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
$
1,597 
 
$
1,497 
 
$
542 
 
$
544 
 
$
408 
 
$
20 
 
$
4,608 
 
Depreciation 
(1)
$
308 
 
$
81 
 
$
61 
 
$
53 
 
$
30 
 
$
20 
 
$
553 
 
Amortization of purchased intangibles
 
 
 
$
17 
 
 
 
 
 
 
 
$
10 
 
 
 
 
$
27 
 
Research, development and engineering expenses 
(2)
$
50 
 
$
68 
 
$
46 
 
$
60 
 
$
11 
 
$
89 
 
$
324 
 
Restructuring, impairment and other charges
 
 
 
$
(1)
 
 
 
 
$
 
 
 
 
 
 
 
$
 
Equity in earnings of affiliated companies
$
(5)
 
 
 
 
 
 
 
 
 
 
 
 
 
$
 
$
 
Income tax (provision) benefit
$
(268)
 
$
(66)
 
$
(45)
 
$
(43)
 
$
(17)
 
$
44 
 
$
(395)
 
Net income (loss) 
(3)
$
597 
 
$
134 
 
$
94 
 
$
82 
 
$
34 
 
$
(93)
 
$
848 
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
 
Three months ended
June 30,
 
Six months ended
June 30,
 
2016
 
2015
 
2016
 
2015
Net income of reportable segments
$
373 
 
$
488 
 
$
671 
 
$
941 
Net loss of All Other
 
(55)
 
 
(45)
 
 
(140)
 
 
(93)
Unallocated amounts:
 
 
 
 
 
 
 
 
 
 
 
Net financing costs 
(1)
 
(29)
 
 
(25)
 
 
(58)
 
 
(49)
Stock-based compensation expense
 
(14)
 
 
(15)
 
 
(23)
 
 
(25)
Exploratory research
 
(28)
 
 
(28)
 
 
(55)
 
 
(54)
Corporate contributions
 
(16)
 
 
(12)
 
 
(23)
 
 
(24)
Gain on realignment of equity investment
 
2,676 
 
 
 
 
 
2,676 
 
 
 
Equity in earnings of affiliated companies, net of impairments 
(2)
 
48 
 
 
59 
 
 
104 
 
 
153 
Unrealized loss on foreign currency hedges related to translated earnings
 
(1,253)
 
 
(10)
 
 
(2,203)
 
 
(130)
Resolution of Department of Justice investigation
 
(98)
 
 
 
 
 
(98)
 
 
 
Income tax benefit
 
653 
 
 
95 
 
 
1,054 
 
 
197 
Other corporate items 
 
(50)
 
 
(11)
 
 
(66)
 
 
(13)
Net income
$
2,207 
 
$
496 
 
$
1,839 
 
$
903